Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.96
-0.05 (-0.71%)
Sep 9, 2025, 10:10 AM - Market open

Journey Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
183821073490-
Upgrade
Market Cap Growth
48.19%-23.38%212.54%-61.94%--
Upgrade
Enterprise Value
189808525109-
Upgrade
Last Close Price
7.013.915.761.925.38-
Upgrade
PS Ratio
2.731.461.350.461.42-
Upgrade
PB Ratio
8.554.075.242.012.13-
Upgrade
P/TBV Ratio
--1692.20-3.04-
Upgrade
P/FCF Ratio
--20.35---
Upgrade
P/OCF Ratio
--20.35---
Upgrade
EV/Sales Ratio
3.361.431.070.331.73-
Upgrade
EV/EBITDA Ratio
--17.57---
Upgrade
EV/EBIT Ratio
--79.43---
Upgrade
EV/FCF Ratio
--16.22---
Upgrade
Debt / Equity Ratio
1.311.280.871.570.221.76
Upgrade
Debt / EBITDA Ratio
--3.59--1.93
Upgrade
Debt / FCF Ratio
--3.38--3.52
Upgrade
Asset Turnover
0.770.720.870.730.851.04
Upgrade
Inventory Turnover
1.681.701.882.564.5412.91
Upgrade
Quick Ratio
0.890.871.020.901.401.15
Upgrade
Current Ratio
1.271.371.351.161.641.26
Upgrade
Return on Equity (ROE)
-57.22%-72.60%-20.64%-100.39%-168.12%81.00%
Upgrade
Return on Assets (ROA)
-5.86%-10.88%0.73%-16.99%-15.79%11.44%
Upgrade
Return on Capital (ROIC)
-10.91%-20.39%1.64%-36.32%-29.64%23.71%
Upgrade
Return on Capital Employed (ROCE)
--3.10%--32.90%
Upgrade
Earnings Yield
-4.74%-17.96%-3.61%-86.86%-49.09%-
Upgrade
FCF Yield
-1.47%-11.17%4.92%-39.68%-2.43%-
Upgrade
Buyback Yield / Dilution
-14.33%-12.06%-4.00%-72.05%5.96%-7.55%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q